scpharmaceuticals.com (SCPH) - Koefisien utang jangka dawa marang modal

scPharmaceuticals - logo grafis emiten SCPH

The scPharmaceuticals Inc. (SCPH) price chart demonstrates the dynamics of an asset whose cash flow is steadily growing due to recognized heart failure treatment methods. The current indicator is 0.00. The business relies on strict control over the transportation of subcutaneous agents, guaranteeing the quality of therapy. The model generates profit through its resilience to market volatility, as demand for these drugs is independent of seasonality or economic conditions.

scpharmaceuticals.com (SCPH): Utang jangka dawa marang ekuitas saka 04.07.2022 nganti 18.10.2025
Produk mawa merek scPharmaceuticals, Inc.

To objectively assess the operational resilience of scPharmaceuticals Inc. (SCPH), investors must understand the balance between debt and equity. Analyzing the long-term debt-to-capital ratio, which reflects the proportion of loans with maturities exceeding one year, allows for an assessment of leverage risk amid uncertainty regarding the commercial success of Furoscix and the challenges of securing insurance reimbursements with limited capital.

Analisis perusahaan pesaing

Haleon PLC - Kewajiban jangka dawa marang ekuitas|Utang jangka dawa marang modal KVUE|VRNA (Verona Pharma Inc.) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal MENS (Jyong Biotech Ltd)|Utang jangka dawa marang modal ligand.com LGND|AMRX - Utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal PRGO (Perrigo Company PLC)|Alvotech Corp (ALVO) - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang ekuitas Liquidia Inc.|GLPG (Galapagos NV) - Utang jangka dawa marang modal|Utang jangka dawa marang modal anipharmaceuticals.com|Rasio utang jangka dawa marang ekuitas MNKD (MannKind)|AMPH (Amphastar Pharmaceuticals Inc) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Pacira PCRX|ARS Corp (SPRY) - Kewajiban jangka dawa marang modal|TBPH: Rasio utang jangka dawa marang ekuitas|aquestive.com - Rasio silihan jangka dawa marang modal|TECX: Utang jangka dawa marang modal|Tonix Pharma - Koefisien utang jangka dawa marang modal|SXTC (SXT Pharmaceuticals) - Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal Eupraxia Pharma EPRX|Utang jangka dawa marang ekuitas BioHarvest Sciences (BHST)|EXOZ (invizyne.com) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Oramed Pharmaceuticals Inc. ORMP|Rasio tanggungan utang jangka dawa marang modal Entera Bio Ltd (ENTX)|MindWalk - Utang jangka dawa marang modal|ABVC BioPharma, Inc (ABVC) - Rasio utang jangka dawa marang ekuitas|Cumberland Pharmaceuticals (CPIX) - Utang jangka dawa marang ekuitas|Kewajiban jangka dawa marang ekuitas QNTM (quantumbiopharma.com)|FGEN (FibroGen) - Utang jangka dawa marang modal|TELO: Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal RANI|Utang jangka dawa marang modal synergychc.com (SNYR)|Utang jangka dawa marang ekuitas Rallybio RLYB|Koefisien utang jangka dawa marang modal LEXX|PULM - Utang jangka dawa marang ekuitas|Pheton Holdings Ltd (PTHL) - Rasio utang jangka dawa marang ekuitas|APM: Utang jangka dawa marang modal|Lyra Therapeutics Inc (LYRA) - Utang jangka dawa marang modal|IBO (Impact BioMedical Inc) - Utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas TNF Pharma (TNFA)|Utang jangka dawa marang modal YCBD|PRFX - Kewajiban jangka dawa marang modal|Altamira Therapeutics Ltd. - Rasio utang jangka dawa marang ekuitas|Utang jangka dawa marang modal Lipella Pharma LIPO|OPTN: Rasio utang jangka dawa marang ekuitas|pieris.com - Rasio silihan jangka dawa marang modal|PROC: Utang jangka dawa marang modal|PTPI - Rasio tanggungan utang jangka dawa marang modal|QLI (Qilian International Holding Group Limited) - Utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas ACELYRIN Inc. (SLRN)|Utang jangka dawa marang modal TFFP